ChomiX Biotech Announces millions of dollars Series Pre-A+ Financing to accelerate the development of Chemoproteomics Platform
NANJING, China, May 15, 2023 /PRNewswire/ -- Recently, ChomiX Biotech Co., Ltd. (hereinafter referred to as ChomiX), a leading biotechnology company focusing on the preclinical development of innovative small molecule drugs, announced the completion of millions of dollars Pre-A+ Financing by TigerYeah Capital,old shareholder Tsinghua Innovation Ventures, and Morning Spring Venture. The proceeds will be used to further...
Treasure Global Announces Strategic Brand Partnership For Zstore Affiliate Program Enhancing Its Health and Wellness E-Commerce Solution
- Zstore Named Sole Marketing And Selling Platform Of enogy Brand Health and Wellness Products - NEW YORK AND KUALA LUMPUR, Malaysia, May 15, 2023 /PRNewswire/ -- Treasure Global Inc (NASDAQ: TGL) ("Treasure Global," or the "Company"), an innovative technology solutions provider for the F&B industry, today announced an exclusive partnership with enogy, a health and wellness brand, to...
Meihua International Medical Technologies Co., Ltd.’s Subsidiary to Attend and Showcase 12 New Products at the 87th China International Medical Equipment Fair
YANGZHOU, China, May 15, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that its wholly-owned subsidiary, Jiangsu Huadong Medical Device Industrial Co., Ltd. ("Jiangsu Huadong"), has been invited to participate in...
Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F for Treatment of Refractory Systemic Lupus Erythematosus (SLE)
Gracell announces start of investigator-initiated trial to expand clinical evaluation of FasTCAR-T GC012F into autoimmune disease GC012F pioneers the use of CD19/BCMA dual-targeting CAR-T in SLE, aiming for deeper and wider depletion of autoantibodies producing B-cells and plasma cells SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, May 15, 2023 /PRNewswire/ -- Gracell...
Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma
Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 mAb, in combination with cetuximab, an anti-EGFR mAb, in sqNSCLC HMBD-001 used as monotherapy and in combination with cetuximab has been shown to effectively inhibit tumor growth across various preclinical squamous cell...
Boosting health equity in the world of climate change
Between 2030 and 2050, climate change is expected to cause approximately 250 000 additional deaths per year from malnutrition, malaria, diarrhoea and heat stress alone - WHO Join 200 policy and topic leaders to explore the health risks and impacts of climate change on healthcare SINGAPORE, May 15, 2023 /PRNewswire/ -- Policymakers, health experts, climate experts, business leaders,...
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time System Monitoring, and is the Only Immunoassay Analyzer with No Daily Maintenancei NT-proBNP Assay Now Available...
Fertility Counts: Merck Launch New Initiative to Underscore the Importance of Sustainable Population Growth in APAC-Region
Fertility Counts seeks to highlight the socio-economic impact of low birth rates on Asia-Pacific (APAC) economies. New Fertility Policy Toolkit, designed by Economist Impact and supported by Merck, proposes evidence-based policy interventions to build more family-friendly societies in APAC. LONDON, May 15, 2023 /PRNewswire/ -- Merck, a leading science and...
TVM Capital Healthcare opens office in Riyadh, Saudi Arabia
DUBAI, UAE and RIYADH, Saudi Arabia, May 15, 2023 /PRNewswire/ -- TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced today the opening of a new office in the capital of the Kingdom of Saudi Arabia. The purpose of the new office is to advise the group...
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
SHANGHAI, May 15, 2023 /PRNewswire/ -- Rona Therapeutics, Inc ("Rona") and Keymed Biosciences ("Keymed", HKEX: 02162), today announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis (also referred as severe kidney diseases). The collaboration will leverage both companies' scientific and technological expertise and will build on Rona's proprietary platform in RNAi targeting liver and extrahepatic...
